Featured Article

The research details how the aging immune system contributes to tumor growth and offers potential new avenues for cancer prevention, particularly for older adults.

Precision Oncology Today

Magazine

Applying Precision Technology to Tackle Climate-Driven Infectious Diseases

The devastating impact that infectious diseases can have on the global population was well demonstrated by the COVID-19 pandemic. Fortunately, pandemics remain unusual occurrences, but research suggests that factors such as climate change may be increasing the risk of such events occurring in the future. Integrative projects that simultaneously tackle infectious disease risks, climate change, and other environmental issues could help solve a complicated global problem.
Blood Testing

Minimal Disease, Maximum Benefit

As both flow cytometry technology and genomic sequencing have taken technological leaps forward, the sensitivity and specificity of testing has increased to include MRD for solid tumors. Leveraging advances in next-generation sequencing, MRD test developers can look for thousands of disease markers and even detect one cancerous cell among a million healthy cells. This level of sensitivity provides evidence of disease recurrence months before traditional follow-up screening methods.
Antibodies Background

Immunogenomics is on the Way Up

Combining immune-system science, omics, and various computational algorithms might produce success where advanced cancer treatments have failed.

Trending on Inside Precision Medicine

immune system

Study Sheds Light on How Aging Immune System Drives Cancer Development

The research details how the aging immune system contributes to tumor growth and offers potential new avenues for cancer prevention, particularly for older adults.
Bald Woman Receiving Chemotherapy Treatment

Gastrointestinal Chemotherapy Tweak Can Reduce Side Effects

Simply using 5-fluorouracil infusion and omitting the initial bolus, quick-delivery injection in multi-drug chemotherapy regimens for advanced gastrointestinal cancers can reduce treatment toxicity without affecting survival, a study suggests.
3D Illustration of human kidneys to illustrate kidney transplants

eGenesis Raises $191 Million for Gene Edited Pig Organs

Xenotransplantation pioneer eGenesis has closed a $191 million financing that will go toward advancing the company's lead candidate, EGEN-2784, a first-in-human study for kidney transplant.

Daily News

Related Content

Inside Precision Medicine